Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kaitlyn O'Keefe
Institution:
Levine Cancer Institute
Observed institutions:
Levine Cancer Institute,
Wake Forest University
ORCID:
0009-0005-2217-1278
Observed ORCID:
0009-0005-2217-1278
OpenAlex ID:
A5003436557
Practical Guidance on Abemaciclib in Combination with Adjuvant Endocrine Therapy for Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative High-Risk Early Breast Cancer
2024
·
Kaitlyn O'Keefe
, Neelam Desai
, et al.
·
Breast Cancer Targets and Therapy
·
11
PDF
Human Epidermal Growth Factor Receptor 2 Alterations and Prognostic Implications in All Subtypes of Breast Cancers
2025
·
Arielle L. Heeke
, Andrew Elliott
, et al.
·
JCO Precision Oncology
·
4
HER2 alterations and prognostic implications in all subtypes of breast cancer.
2022
·
Kaitlyn O'Keefe
, Andrew Elliott
, et al.
·
Journal of Clinical Oncology
·
4
Show more works
View as search
Works count:
3
Citation count:
19
H-index:
3
I10-index:
1
Year
Topic
Type